Φορτώνει......
Immune checkpoint blockade in advanced hepatocellular carcinoma: an update and critical review of ongoing clinical trials
Systemic treatments for advanced hepatocellular carcinoma (HCC) are evolving rapidly and several multi-targeted tyrosine kinase inhibitors have demonstrated a survival advantage over best supportive care. Despite these treatment advances, the majority of HCC patients will progress on tyrosine kinase...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Future Oncol |
|---|---|
| Κύριος συγγραφέας: | |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Future Medicine Ltd
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7444624/ https://ncbi.nlm.nih.gov/pubmed/29663837 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/fon-2018-0008 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|